188 related articles for article (PubMed ID: 30674889)
1. ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.
Guo T; Wen XZ; Li ZY; Han HB; Zhang CG; Bai YH; Xing XF; Cheng XJ; Du H; Hu Y; Wang XH; Jia YN; Nie ML; Xie M; Li QD; Ji JF
Cell Death Dis; 2019 Jan; 10(2):33. PubMed ID: 30674889
[TBL] [Abstract][Full Text] [Related]
2. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
[TBL] [Abstract][Full Text] [Related]
3. ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.
Shi Q; Wang W; Jia Z; Chen P; Ma K; Zhou C
Oncotarget; 2016 Jun; 7(24):36489-36500. PubMed ID: 27183908
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of islet-1 serine 269 by CDK1 increases its transcriptional activity and promotes cell proliferation in gastric cancer.
Shi Q; Ni X; Lei M; Xia Q; Dong Y; Zhang Q; Wang W
Mol Med; 2021 May; 27(1):47. PubMed ID: 33962568
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
[TBL] [Abstract][Full Text] [Related]
8. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression.
Shen H; Zhu H; Chen Y; Shen Z; Qiu W; Qian C; Zhang J
Cell Death Dis; 2021 Apr; 12(4):349. PubMed ID: 33824282
[TBL] [Abstract][Full Text] [Related]
9. USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics.
Liu YJ; Zeng SH; Zhang W; Li JP; Yin Y; Zhuang YW; Zhou JY; Liu SL; Zou X
Pharmacol Res; 2023 Feb; 188():106644. PubMed ID: 36603607
[TBL] [Abstract][Full Text] [Related]
10. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
11. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
12. The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.
Yin Y; Liu W; Shen Q; Zhang P; Wang L; Tao R; Li H; Ma X; Zeng X; Cheong JH; Song S; Ajani JA; Mills GB; Tao K; Peng G
Mol Cancer Ther; 2019 Aug; 18(8):1439-1450. PubMed ID: 31142662
[TBL] [Abstract][Full Text] [Related]
13. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
14. MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Su L; Luo Y; Yang Z; Yang J; Yao C; Cheng F; Shan J; Chen J; Li F; Liu L; Liu C; Xu Y; Jiang L; Guo D; Prieto J; Ávila MA; Shen J; Qian C
Cancer Res; 2016 Sep; 76(17):5054-67. PubMed ID: 27364559
[TBL] [Abstract][Full Text] [Related]
15. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
[TBL] [Abstract][Full Text] [Related]
17. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
18. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of ANO1 promotes gastric cancer progression.
Zeng X; Pan D; Wu H; Chen H; Yuan W; Zhou J; Shen Z; Chen S
Biochem Biophys Res Commun; 2019 Apr; 512(1):131-136. PubMed ID: 30871776
[TBL] [Abstract][Full Text] [Related]
20. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
